These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 33827421)
1. Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial. Khani S; Hejazi SA; Yaghoubi M; Sharifipour E J Headache Pain; 2021 Apr; 22(1):21. PubMed ID: 33827421 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Bidabadi E; Mashouf M Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study. Karimi N; Razian A; Heidari M Acta Neurol Belg; 2021 Feb; 121(1):167-173. PubMed ID: 30798472 [TBL] [Abstract][Full Text] [Related]
4. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study. Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282 [TBL] [Abstract][Full Text] [Related]
5. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial. Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342 [TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial. Kashipazha D; Ghadikolaei HS; Siavashi M Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053 [TBL] [Abstract][Full Text] [Related]
7. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial. Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814 [TBL] [Abstract][Full Text] [Related]
8. The effects of cinnarizine versus sodium valproate in migraine prophylaxis. Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688 [TBL] [Abstract][Full Text] [Related]
9. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study. Dakhale GN; Sharma VS; Thakre MN; Kalikar M Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis. Afshari D; Rafizadeh S; Rezaei M Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
12. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Tanen DA; Miller S; French T; Riffenburgh RH Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study. Millán-Guerrero RO; Isais-Millán R; Barreto-Vizcaíno S; Rivera-Castaño L; Garcia-Solorzano A; López-Blanca C; Membrila-Maldonado M; Muñoz-Solis R Eur J Neurol; 2007 Oct; 14(10):1079-84. PubMed ID: 17880560 [TBL] [Abstract][Full Text] [Related]
17. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study. Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029 [TBL] [Abstract][Full Text] [Related]
18. Intravenous ibuprofen versus sodium valproate in acute migraine attacks in the emergency department: A randomized clinical trial. Dogruyol S; Gur STA; Akbas I; Kocak MB; Kocak AO; Ceylan M; Tekyol D Am J Emerg Med; 2022 May; 55():126-132. PubMed ID: 35313227 [TBL] [Abstract][Full Text] [Related]
19. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Hering R; Kuritzky A Cephalalgia; 1992 Apr; 12(2):81-4. PubMed ID: 1576648 [TBL] [Abstract][Full Text] [Related]